Matches in SemOpenAlex for { <https://semopenalex.org/work/W2962678606> ?p ?o ?g. }
- W2962678606 endingPage "107717" @default.
- W2962678606 startingPage "107717" @default.
- W2962678606 abstract "Abstract Rationale The second generation antipsychotic drug clozapine is a psychotherapeutic agent with superior efficacy for treatment-resistant schizophrenia. Clozapine is associated with a low likelihood of neurological side-effects, but a high propensity to induce weight gain and metabolic dysregulation. The primary metabolite of clozapine is norclozapine (N-Desmethylclozapine), which has psychoactive properties itself, but its effects on metabolic function remains unknown. The goal of the present study was to determine whether directly administered norclozapine could cause metabolic dysregulation, similar to clozapine. Methods Adult female rats were treated with a range of doses of clozapine and norclozapine (0.5, 2, 8 & 20 mg/kg, i.p.) and then subjected to the intraperitoneal glucose tolerance test (IGTT), where glucose levels were recorded for 2 h following a glucose challenge. In parallel, rats were tested with two doses of clozapine and norclozapine (2 & 20 mg/kg, i.p.) in the hyperinsulinemic-euglycemic clamp (HIEC), to measure whole body insulin resistance. Results In the IGTT, clozapine demonstrated dose-dependent effects on fasting glucose levels and total glucose area-under-the-curve following the glucose challenge, with the two highest doses strongly increasing glucose levels. Only the highest dose of norclozapine increased fasting glucose levels, and caused a non-significant increase in glucose levels following the challenge. By contrast, both doses of clozapine and norclozapine caused a potent and long-lasting decrease in the glucose infusion rate in the HIEC, indicating that both compounds cause whole body insulin resistance. Abstract While not as potent as its parent compound, norclozapine clearly exerts acute metabolic effects, particularly on insulin resistance. This article is part of the issue entitled ‘Special Issue on Antipsychotics’." @default.
- W2962678606 created "2019-07-30" @default.
- W2962678606 creator A5016507063 @default.
- W2962678606 creator A5021212855 @default.
- W2962678606 creator A5033183852 @default.
- W2962678606 creator A5033207503 @default.
- W2962678606 creator A5072032034 @default.
- W2962678606 creator A5076806422 @default.
- W2962678606 creator A5089103560 @default.
- W2962678606 date "2020-09-01" @default.
- W2962678606 modified "2023-09-27" @default.
- W2962678606 title "A comparison of the effects of clozapine and its metabolite norclozapine on metabolic dysregulation in rodent models" @default.
- W2962678606 cites W131681483 @default.
- W2962678606 cites W1963694359 @default.
- W2962678606 cites W1970681651 @default.
- W2962678606 cites W1978991003 @default.
- W2962678606 cites W1980149418 @default.
- W2962678606 cites W1997108868 @default.
- W2962678606 cites W2003624514 @default.
- W2962678606 cites W2005393609 @default.
- W2962678606 cites W2006647811 @default.
- W2962678606 cites W2007656372 @default.
- W2962678606 cites W2011180752 @default.
- W2962678606 cites W2012107796 @default.
- W2962678606 cites W2016278859 @default.
- W2962678606 cites W2025086223 @default.
- W2962678606 cites W2025235181 @default.
- W2962678606 cites W2031493607 @default.
- W2962678606 cites W2032636178 @default.
- W2962678606 cites W2032902988 @default.
- W2962678606 cites W2037168505 @default.
- W2962678606 cites W2039425202 @default.
- W2962678606 cites W2041281069 @default.
- W2962678606 cites W2043535894 @default.
- W2962678606 cites W2046479063 @default.
- W2962678606 cites W2049832659 @default.
- W2962678606 cites W2050023063 @default.
- W2962678606 cites W2050584393 @default.
- W2962678606 cites W2054115083 @default.
- W2962678606 cites W2055001682 @default.
- W2962678606 cites W2055782708 @default.
- W2962678606 cites W2056015509 @default.
- W2962678606 cites W2058115846 @default.
- W2962678606 cites W2058759340 @default.
- W2962678606 cites W2059233544 @default.
- W2962678606 cites W2062009247 @default.
- W2962678606 cites W2062097228 @default.
- W2962678606 cites W2069885067 @default.
- W2962678606 cites W2073146153 @default.
- W2962678606 cites W2075458309 @default.
- W2962678606 cites W2110025065 @default.
- W2962678606 cites W2111105929 @default.
- W2962678606 cites W2114103060 @default.
- W2962678606 cites W2119704634 @default.
- W2962678606 cites W2156509485 @default.
- W2962678606 cites W2164418602 @default.
- W2962678606 cites W2167797472 @default.
- W2962678606 cites W2329633368 @default.
- W2962678606 cites W2332600596 @default.
- W2962678606 cites W2401262157 @default.
- W2962678606 cites W2480374316 @default.
- W2962678606 cites W2485011967 @default.
- W2962678606 cites W2725805887 @default.
- W2962678606 cites W2760909292 @default.
- W2962678606 cites W2765789483 @default.
- W2962678606 cites W2766496673 @default.
- W2962678606 cites W2789453015 @default.
- W2962678606 cites W4322388555 @default.
- W2962678606 cites W1984746800 @default.
- W2962678606 doi "https://doi.org/10.1016/j.neuropharm.2019.107717" @default.
- W2962678606 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/31348941" @default.
- W2962678606 hasPublicationYear "2020" @default.
- W2962678606 type Work @default.
- W2962678606 sameAs 2962678606 @default.
- W2962678606 citedByCount "9" @default.
- W2962678606 countsByYear W29626786062020 @default.
- W2962678606 countsByYear W29626786062021 @default.
- W2962678606 crossrefType "journal-article" @default.
- W2962678606 hasAuthorship W2962678606A5016507063 @default.
- W2962678606 hasAuthorship W2962678606A5021212855 @default.
- W2962678606 hasAuthorship W2962678606A5033183852 @default.
- W2962678606 hasAuthorship W2962678606A5033207503 @default.
- W2962678606 hasAuthorship W2962678606A5072032034 @default.
- W2962678606 hasAuthorship W2962678606A5076806422 @default.
- W2962678606 hasAuthorship W2962678606A5089103560 @default.
- W2962678606 hasConcept C118552586 @default.
- W2962678606 hasConcept C126322002 @default.
- W2962678606 hasConcept C18903297 @default.
- W2962678606 hasConcept C2776412080 @default.
- W2962678606 hasConcept C2777477808 @default.
- W2962678606 hasConcept C2778914748 @default.
- W2962678606 hasConcept C2780864610 @default.
- W2962678606 hasConcept C2992558993 @default.
- W2962678606 hasConcept C70721500 @default.
- W2962678606 hasConcept C71924100 @default.
- W2962678606 hasConcept C86803240 @default.
- W2962678606 hasConcept C98274493 @default.
- W2962678606 hasConceptScore W2962678606C118552586 @default.